Literature DB >> 20882610

Dynamic susceptibility contrast perfusion weighted imaging in grading of nonenhancing astrocytomas.

Naomi Morita1, Sumei Wang, Sanjeev Chawla, Harish Poptani, Elias R Melhem.   

Abstract

PURPOSE: To evaluate if the relative tumor blood volume (rTBV) using dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) can aid in distinguishing low- from high-grade nonenhancing astrocytomas.
MATERIALS AND METHODS: Seventeen patients with histologically proven astrocytomas underwent MRI including DSC-MRI. Maximum TBV regions of interest were recorded from each neoplasm and normalized to contralateral normal white matter. Demographic features, diagnostic MRI findings including tumor volumes, and the normalized rTBV ratios were compared between low-grade (I and II, LGA, n = 6) and high-grade (III) astrocytomas (HGA, n = 11) using Mann-Whitney's U-test and receiver operating characteristic (ROC) analysis.
RESULTS: Maximum rTBV ratios were statistically higher for HGA (1.11 ± 0.13) than LGA (0.66 ± 0.17, P < 0.005) with the best cutoff threshold at 0.94 (sensitivity of 90.9%, specificity of 100%). Differences in mean age and tumor volume on fluid-attenuated inversion recovery (FLAIR) imaging between the two groups did not reach statistical difference (P = 0.22, 0.36).
CONCLUSION: The addition of DSC-MRI can aid in accurate grading of nonenhancing astrocytomas with high sensitivity and specificity.

Entities:  

Mesh:

Year:  2010        PMID: 20882610     DOI: 10.1002/jmri.22324

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  21 in total

1.  Prognostic Value of Dynamic Susceptibility Contrast-Enhanced and Diffusion-Weighted MR Imaging in Patients with Glioblastomas.

Authors:  G Çoban; S Mohan; F Kural; S Wang; D M O'Rourke; H Poptani
Journal:  AJNR Am J Neuroradiol       Date:  2015-04-02       Impact factor: 3.825

2.  Advanced MR imaging techniques in the evaluation of nonenhancing gliomas: perfusion-weighted imaging compared with proton magnetic resonance spectroscopy and tumor grade.

Authors:  Neslin Sahin; Elias R Melhem; Sumei Wang; Jaroslaw Krejza; Harish Poptani; Sanjeev Chawla; Gaurav Verma
Journal:  Neuroradiol J       Date:  2013-11-07

3.  Preoperative grading of supratentorial nonenhancing gliomas by high b-value diffusion-weighted 3 T magnetic resonance imaging.

Authors:  Haiwei Han; Chengkun Han; Xiurong Wu; Shan Zhong; Xiongjie Zhuang; Guowei Tan; Hua Wu
Journal:  J Neurooncol       Date:  2017-04-24       Impact factor: 4.130

4.  Characterization and therapy monitoring of head and neck carcinomas using diffusion-imaging-based intravoxel incoherent motion parameters-preliminary results.

Authors:  Thomas Hauser; Marco Essig; Alexandra Jensen; Lars Gerigk; Frederik Bernd Laun; Marc Münter; Dirk Simon; Bram Stieltjes
Journal:  Neuroradiology       Date:  2013-02-17       Impact factor: 2.804

5.  Gadolinium retention in gliomas and adjacent normal brain tissue: association with tumor contrast enhancement and linear/macrocyclic agents.

Authors:  Aida Kiviniemi; Maria Gardberg; Paul Ek; Janek Frantzén; Johan Bobacka; Heikki Minn
Journal:  Neuroradiology       Date:  2019-02-02       Impact factor: 2.804

6.  Advanced MRI may complement histological diagnosis of lower grade gliomas and help in predicting survival.

Authors:  Valeria Cuccarini; A Erbetta; M Farinotti; L Cuppini; F Ghielmetti; B Pollo; F Di Meco; M Grisoli; G Filippini; G Finocchiaro; M G Bruzzone; M Eoli
Journal:  J Neurooncol       Date:  2016-01       Impact factor: 4.130

Review 7.  Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.

Authors:  Jill M Abrigo; Daniel M Fountain; James M Provenzale; Eric K Law; Joey Sw Kwong; Michael G Hart; Wilson Wai San Tam
Journal:  Cochrane Database Syst Rev       Date:  2018-01-22

8.  Differentiation between oligodendroglioma genotypes using dynamic susceptibility contrast perfusion-weighted imaging and proton MR spectroscopy.

Authors:  S Chawla; J Krejza; A Vossough; Y Zhang; G S Kapoor; S Wang; D M O'Rourke; E R Melhem; H Poptani
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-31       Impact factor: 3.825

Review 9.  Discriminating radiation necrosis from tumor progression in gliomas: a systematic review what is the best imaging modality?

Authors:  Ashish H Shah; Brian Snelling; Amade Bregy; Payal R Patel; Danoushka Tememe; Rita Bhatia; Evelyn Sklar; Ricardo J Komotar
Journal:  J Neurooncol       Date:  2013-01-24       Impact factor: 4.130

10.  Contrast Leakage Patterns from Dynamic Susceptibility Contrast Perfusion MRI in the Grading of Primary Pediatric Brain Tumors.

Authors:  C Y Ho; J S Cardinal; A P Kamer; C Lin; S F Kralik
Journal:  AJNR Am J Neuroradiol       Date:  2015-11-12       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.